NO20005724L - Biologisk aktiv sammensetning - Google Patents

Biologisk aktiv sammensetning

Info

Publication number
NO20005724L
NO20005724L NO20005724A NO20005724A NO20005724L NO 20005724 L NO20005724 L NO 20005724L NO 20005724 A NO20005724 A NO 20005724A NO 20005724 A NO20005724 A NO 20005724A NO 20005724 L NO20005724 L NO 20005724L
Authority
NO
Norway
Prior art keywords
biologically active
active agent
carrier
active composition
chemical reaction
Prior art date
Application number
NO20005724A
Other languages
English (en)
Other versions
NO20005724D0 (no
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Benediktsson
Rickard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of NO20005724D0 publication Critical patent/NO20005724D0/no
Publication of NO20005724L publication Critical patent/NO20005724L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Oppfinnelsen angår en ny biologisk aktiv sammensetning som innbefatter et biologisk aktivt middel som skal frigis derfra, hvor nevnte biologisk aktive middel er oppløst og/eller dispergert i en overmettet tilstand innenfor en bærer, hvorved bæreren innbefatter en flytende og/eller fast ikke-krystallinsk ester og/eller polyestermatriks og hvor presipitering av nevnte biologisk aktive middel er i det vesentlige, eller fullstendig, inhibert deri. Nevnte overmettede tilstand kan oppnås ved å utsette en eller flere bærerstartsubstans(er) for slike kjemiske reaksjon(er) at det tilveiebringes en ester og/eller polyestermatriks, hvor det biologisk aktive middelet tilsettes etter nevnte - kjemiske reaksjon(er), har blitt avsluttet.
NO20005724A 1998-05-14 2000-11-13 Biologisk aktiv sammensetning NO20005724L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000823 WO1999058108A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (2)

Publication Number Publication Date
NO20005724D0 NO20005724D0 (no) 2000-11-13
NO20005724L true NO20005724L (no) 2001-01-09

Family

ID=20411318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005724A NO20005724L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning

Country Status (20)

Country Link
US (1) US6537576B1 (no)
EP (1) EP1082102B1 (no)
JP (1) JP2002514587A (no)
KR (1) KR100592971B1 (no)
CN (1) CN1309553A (no)
AT (1) ATE310500T1 (no)
AU (1) AU736480B2 (no)
CA (1) CA2331527C (no)
DE (2) DE69928524T2 (no)
ES (1) ES2155048T3 (no)
GR (1) GR20010300013T1 (no)
HU (1) HUP0102426A2 (no)
IL (2) IL139576A0 (no)
NO (1) NO20005724L (no)
NZ (1) NZ508073A (no)
PL (1) PL344051A1 (no)
SE (1) SE9801704D0 (no)
TR (1) TR200003589T2 (no)
WO (1) WO1999058108A1 (no)
ZA (1) ZA200006474B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
MX2008015599A (es) 2006-06-14 2009-03-06 Reddys Lab Ltd Dr Composiciones topicas.
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
KR20110082142A (ko) * 2008-10-06 2011-07-18 밀란 테크놀로지즈 인코포레이티드 비정질 로티고틴 경피 시스템
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
JP2002514587A (ja) 2002-05-21
AU736480B2 (en) 2001-07-26
IL139576A (en) 2007-07-04
TR200003589T2 (tr) 2001-03-21
NO20005724D0 (no) 2000-11-13
DE1082102T1 (de) 2001-09-06
ES2155048T1 (es) 2001-05-01
DE69928524D1 (de) 2005-12-29
EP1082102A1 (en) 2001-03-14
ZA200006474B (en) 2001-09-04
PL344051A1 (en) 2001-09-24
CN1309553A (zh) 2001-08-22
CA2331527C (en) 2010-04-13
KR100592971B1 (ko) 2006-06-23
HUP0102426A2 (hu) 2002-03-28
KR20010052348A (ko) 2001-06-25
NZ508073A (en) 2002-12-20
DE69928524T2 (de) 2006-08-10
SE9801704D0 (sv) 1998-05-14
GR20010300013T1 (en) 2001-04-30
ES2155048T3 (es) 2006-06-16
ATE310500T1 (de) 2005-12-15
WO1999058108A1 (en) 1999-11-18
AU4405099A (en) 1999-11-29
EP1082102B1 (en) 2005-11-23
IL139576A0 (en) 2002-02-10
US6537576B1 (en) 2003-03-25
CA2331527A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
JP3411195B2 (ja) 活性酸素除去剤
BRPI0413432A (pt) método de esterificação de amido
van Iterson et al. A cytochemical localization of reductive sites in a Gram-negative bacterium: tellurite reduction in Proteus vulgaris
NO20005724L (no) Biologisk aktiv sammensetning
TR200200822T2 (tr) Uçucu bileşiklerin sıvı solüsyon içindeki katı maddelerden çıkarılması süreci
Guillory et al. Covalent labeling of the tetrodotoxin receptor in excitable membranes
PT1224455E (pt) Processo de separacao de um composto quimico ou biologico numa mistura de compostos similares por difusao num meio tal como um gel
NO20005725D0 (no) Biologisk aktiv sammensetning
TR200000442T2 (tr) Sıvı deterjan bileşimleri ve bunları hazırlamak için işlem.
Kurin-Csörgei et al. On the nature of patterns arising during polymerization of acrylamide in the presence of the methylene blue-sulfide-oxygen oscillating reaction
BR9915484A (pt) Processo para o isolamento contìnuo de proteìnas ativas
BRPI0514743A (pt) métodos de isolamento de 1, 3-propanodiol e de 1, 2-propanodiol
TW200506531A (en) Photoresist composition for deep uv and process thereof
Quastel The mechanism of bacterial action
BR9807726A (pt) Processo para a preparação de um composto
Schaltegger et al. Dithranol: Further Investigations on the Structure-Activity-Relationship: The New Series of the 10-Mono-Alkyldithranol Derivatives
RU1793375C (ru) Способ определени супероксидустран ющей активности
JPS52105282A (en) Immobilization of enzyme
CA2353529A1 (en) Method for reducing free-radical induced injury
Ensor et al. [17] Photoaffinity labeling of NAD+-linked enzymes
JPS5798218A (en) Production of adjuvant-active substance
KR890014025A (ko) 핵용출 화분의 제조방법
KR940002418A (ko) 액체 표백제 조성물
JPS56154992A (en) Heat-resistant immobilized acetate kinase
DE69928254D1 (de) Behandlung von zellen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application